legal-news
1:16-cv-12182 United States of America ex rel. v. Janssen Biotech, Inc.
16-cv-12182
|
|
Filed
Advertisement
description
Case Summary
This entry duplicates the case involving the United States ex relator against Janssen Biotech, Inc., with the same opposition to a motion noted. The case likely concerns allegations of fraud or misconduct under federal statutes, with active procedural disputes ongoing.
Stage
Motion practice
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • False Claims Act
- • Qui tam litigation
- • Motion opposition
- • Government enforcement
Advertisement
Case Timeline
1 event
info
Motion
April 13, 2026
1:16-cv-12182 United States of America ex rel. v. Janssen Biotech, Inc.
In the case United States of America ex rel. v. Janssen Biotech, Inc., one party filed an opposition to a motion, meaning they formally disagreed with a request made to the court. This step is part of the legal process where each side presents arguments to influence the court's decision. Understanding these oppositions helps track how the case is progressing and what issues are contested.
Advertisement
newspaper
1 article